Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FTSE 100 movers: IAG flies higher after results; GSK in the black

(Sharecast News) - London's FTSE 100 was down 1.3% at 8,178.75 in afternoon trade on Friday. IAG flew higher after the BA and Iberia owner said it would start paying dividends again, posted a rise in first-half profits and abandoned its pursuit of Air Europa.

Russ Mould, investment director at AJ Bell, said: "Against a backdrop of airlines slashing prices to fill planes and negative investor sentiment towards the sector, International Consolidated Airlines has issued a remarkably upbeat set of results.

"Strong travel demand over the past few years has enabled the airline to pay down debt and get its finances in order after a traumatic pandemic. The balance sheet is now deemed strong enough to warrant recommencing dividends, something that investors will welcome with open arms.

"Paying dividends also signals a big step forward for the company and effectively draws a line under previous fears about its financial strength. In essence, recommencing the dividend means the narrative can shift to how the business is growing, not simply how it is repairing previous damage.

"Walking away from a proposed takeover of Air Europa also shows the company has discipline and isn't prepared to spend a long time fighting antitrust regulators to get the deal over the line. Management has clearly decided its time is better spent elsewhere and to just move on. Investors often like companies that take decisive action."

GSK was in the black as it said the US Food and Drug Administration has approved its Jemperli treatment in combination with chemotherapy and then use on its own for adult patients with primary advanced or recurrent endometrial cancer.

FTSE 100 - Risers

International Consolidated Airlines Group SA (CDI) (IAG) 169.55p 5.97% GSK (GSK) 1,582.50p 3.70% Haleon (HLN) 369.50p 3.21% National Grid (NG.) 1,000.00p 2.04% AstraZeneca (AZN) 12,740.00p 1.82% Unilever (ULVR) 4,858.00p 1.59% United Utilities Group (UU.) 1,048.00p 1.45% Fresnillo (FRES) 599.00p 1.27% Reckitt Benckiser Group (RKT) 4,149.00p 1.24% Severn Trent (SVT) 2,621.00p 1.24%

FTSE 100 - Fallers

Melrose Industries (MRO) 485.80p -5.67% Intermediate Capital Group (ICG) 2,018.00p -5.35% Pershing Square Holdings Ltd NPV (PSH) 3,600.00p -5.16% Ashtead Group (AHT) 5,194.00p -4.84% Vistry Group (VTY) 1,309.00p -4.52% Scottish Mortgage Inv Trust (SMT) 813.60p -4.46% Barclays (BARC) 213.25p -4.33% Mondi (MNDI) 1,475.50p -4.28% 3i Group (III) 2,969.00p -3.98% Diploma (DPLM) 4,206.00p -3.97%

Share this article

Related Sharecast Articles

London midday: Stocks stay down as China retaliates against US tariffs
(Sharecast News) - London stocks were still in the red by midday on Tuesday as investors mulled the impact of the latest developments in the Trump tariff drama, after China announced retaliatory tariffs on a range of US imports.
Europe midday: Shares pare losses as investors digest China tariff move
(Sharecast News) - European stocks pared losses as investors digested China's retaliatory moves against US tariffs and the 30-day pause on levies against Canada and Mexico.
US pre-open: Futures slightly lower as tariff headlines remain in focus
(Sharecast News) - Wall Street futures were in the red ahead of the bell on Tuesday as the effects of the new White House administration's tariffs on a number of its closest trading partners continued to be seen.
Asia report: Markets bounce back from Trump tariff sell-off
(Sharecast News) - Asia-Pacific markets advanced on Tuesday as investor sentiment improved following Donald Trump's decision to pause tariffs on Mexico and Canada for a month.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.